[Regulation mechanism of fibrinolysis system on vascular wall].

K. Sueishi

1986-10-01

Abstract:

What problem does this paper attempt to address?

A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study

Peng-chao Zhan,Shuo Yang,Xing Liu,Yu-yuan Zhang,Rui Wang,Jia-xing Wang,Qing-ya Qiu,Yu Gao,Dong-bo Lv,Li-ming Li,Cheng-long Luo,Zhi-wei Hu,Zhen Li,Pei-jie Lyu,Pan Liang,Jian-bo Gao

DOI: https://doi.org/10.1186/s12885-024-12174-0

IF: 4.638

2024-04-03

BMC Cancer

Abstract:Accurate microsatellite instability (MSI) testing is essential for identifying gastric cancer (GC) patients eligible for immunotherapy. We aimed to develop and validate a CT-based radiomics signature to predict MSI and immunotherapy outcomes in GC.

oncology
A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing.

Lizhen Zhu,Yanqin Huang,Xuefeng Fang,Chenglin Liu,Wanglong Deng,Chenhan Zhong,Jinghong Xu,Dong Xu,Ying Yuan

DOI: https://doi.org/10.1016/j.jmoldx.2017.11.007

IF: 5.341

2017-01-01

Journal of Molecular Diagnostics

Abstract:Two types of molecular tests have been established to assess the deficiency of the DNA mismatch repair (MMR) system: microsatellite instability (MSI) and immunohistochemical (IHC) analysis. We have developed a reliable method to analyze the MSI status by next-generation sequencing (NGS) based on read-count distribution. A total of 91 patients with primary colorectal cancer were recruited. These patients included 54 cases with loss of expression of any MMR protein in IHC, suggesting deficient MMR (dMMR), and 37 cases of colorectal cancer with staining of all four MMR proteins in IHC, suggesting proficient MMR in the sample after surgery. DNA was extracted from paired tumor-normal tissue for MSI detection by both the ColonCore NGS panel and PCR. The sequencing data from the NGS panel was processed using various MSI detection pipelines for a comparison with the ColonCore panel. Using the MSI-PCR test as the gold standard, MSI-ColonCore achieved 97.9% sensitivity (47 of 48) and 100% specificity (37 of 37) for the detection of MSI status. MSI-ColonCore also showed more efficient and robust performance compared with other NGS-based MSI detection algorithms. The concordance rate was 92.3% between MSI-ColonCore and IHC testing, and 93.4% between MSI-PCR and IHC testing. These results suggest that MSI-ColonCore is a reliable and robust method for MSI status detection by NGS based on read-count distribution.
Raman fiber-optic probe for rapid diagnosis of gastric and esophageal tumors with machine learning analysis or similarity assessments: a comparative study

Shiyan Fang,Pei Xu,Siyi Wu,Zhou Chen,Junqing Yang,Haibo Xiao,Fangbao Ding,Shuchun Li,Jin Sun,Zirui He,Jian Ye,Linley Li Lin

DOI: https://doi.org/10.1007/s00216-024-05545-w

2024-09-25

Abstract:Gastric and esophageal cancers, the predominant forms of upper gastrointestinal malignancies, contribute significantly to global cancer mortality. Routine detection methods, including medical imaging, endoscopic examination, and pathological biopsy, often suffer from drawbacks such as low sensitivity and laborious and complex procedures. Raman spectroscopy is a non-invasive and label-free optical technique that provides highly sensitive biomolecular information to facilitate effective tumor identification. In this work, we report the use of fiber-optic Raman spectroscopy for the accurate and rapid diagnosis of gastric and esophageal cancers. Using a database of 14,000 spectra from 140 ex vivo tissue pieces of both tumor and normal tissue samples, we compare the random forest (RF) and our established Euclidean distance Raman spectroscopy (EDRS) model. The RF analysis achieves a sensitivity of 85.23% and an accuracy of 83.05% in diagnosing gastric tumors. The EDRS algorithm with improved diagnostic transparency further increases the sensitivity to 92.86% and accuracy to 89.29%. When these diagnostic protocols are extended to esophageal tumors, the RF and EDRS models achieve accuracies of 71.27% and 93.18%, respectively. Finally, we demonstrate that fewer than 20 spectra are sufficient to achieve good Raman diagnostic accuracy for both tumor tissues. This optimizes the balance between acquisition time and diagnostic performance. Our work, although conducted on ex vivo tissue models, offers valuable insights for in vivo in situ endoscopic Raman diagnosis of gastric and esophageal cancer lesions in the future. Our study provides a robust, rapid, and convenient method as a new paradigm in in vivo endoscopic medical diagnostics that integrates spectroscopic techniques and a Raman probe for detecting upper gastrointestinal malignancies.
Distinct roles of the mTOR components Rictor and Raptor in MO7e megakaryocytic cells

G. Fuhler,M. Tyl,Sandra G. M. Olthof,A. Lyndsay Drayer,N. Blom,E. Vellenga

DOI: https://doi.org/10.1111/j.1600-0609.2009.01263.x

2009-09-01

European Journal Of Haematology

Abstract:Objective: During megakaryopoiesis, hematopoietic progenitor cells in the bone marrow proliferate and ultimately differentiate in mature megakaryocytes (MK). We and others have recently described a role for the mammalian target of Rapamycin (mTOR) in proliferation and differentiation of MK cells. Two non‐redundant complexes of mTOR have been described; mTORC1 containing rapamycin‐associated TOR protein (Raptor) and mTORC2 containing Rapamycin‐insensitive companion of mTOR (Rictor). The individual roles of these complexes in MK development have so far not been elucidated, and were investigated in this study.
Raman Spectroscopy: A Novel Technology for Gastric Cancer Diagnosis

Kunxiang Liu,Qi Zhao,Bei Li,Xia Zhao

DOI: https://doi.org/10.3389/fbioe.2022.856591

IF: 5.7

2022-03-15

Frontiers in Bioengineering and Biotechnology

Abstract:Gastric cancer is usually diagnosed at late stage and has a high mortality rate, whereas early detection of gastric cancer could bring a better prognosis. Conventional gastric cancer diagnostic methods suffer from long diagnostic times, severe trauma, and a high rate of misdiagnosis and rely heavily on doctors’ subjective experience. Raman spectroscopy is a label-free molecular vibrational spectroscopy technique that identifies the molecular fingerprint of various samples based on the inelastic scattering of monochromatic light. Because of its advantages of non-destructive, rapid, and accurate detection, Raman spectroscopy has been widely studied for benign and malignant tumor differentiation, tumor subtype classification, and section pathology diagnosis. This paper reviews the applications of Raman spectroscopy for the in vivo and in vitro diagnosis of gastric cancer, methodology related to the spectroscopy data analysis, and presents the limitations of the technique.

multidisciplinary sciences
[Studies of Microsatellite Instability in Chinese Gastric Cancer Tissues].

Y Wang,Y Ke,T Ning,L Feng,G Lu,W Liu,Z E

1998-01-01

Abstract:OBJECTIVE:To identify the microsatellite instability(MSI) rates in Chinese gastric cancer samples.METHODS:29 microsatellite markers were selected to examine 42 paired gastric cancer tissues for MSI on all chromosomes except Y.RESULTS:The total frequency of MSI in all 42 gastric cancers was 33.9% with higher rates at loci of D3S1577, D3S1067,D8S279,D9S257, D1S248, D7S520 and D2S147,and the highest rate at D3S1577 and D3S1067(51.35%). MSI varied with different pathological types. The frequencies of MSI were signi- ficantly higher in poorly differentiated tumors and signet cell types, compared with well differentiated tumors(P=0.0026 and 0.0013 by chi-square test),and no difference was noted between poorly differentiated and signet cell types.CONCLUSION:MSI may play an important role in Chinese gastric cancer, particularly the poorly differentiated adenocarcinomas. The data presented here further support the previous hypothesis that pathologically distinct subtypes of gastric cancer undergo different genetic pathways during tumorigenesis.
A Novel Detection Technology for Early Gastric Cancer Based on Raman Spectroscopy.

Fumei Yin,Xiaoyu Zhang,Aoran Fan,Xiangqian Liu,Junfeng Xu,Xianzong Ma,Lang Yang,Hui Su,Hui Xie,Xin Wang,Hanbing Gao,Yilin Wang,Heng Zhang,Xing Zhang,Peng Jin,Jianqiu Sheng

DOI: https://doi.org/10.1016/j.saa.2023.122422

2023-01-01

Abstract:Despite universal endoscopic screening, early detection of gastric cancer is challenging, led researchers to seek for a novel approach in detecting. Raman spectroscopy measurements as a fingerprint of biochemical structure, enable accurate prediction of gastric lesions non-destructively. This study aimed to evaluate the diagnostic power of Raman spectroscopy in early gastric cancer (EGC), and reveal dynamic biomolecular changes in vitro from normal to EGC. To clarify the biochemical alterations in Correa's cascade, Raman spectra of human normal gastric mucosa, intestinal metaplasia, dysplasia, and adenocarcinoma were compared at tissue and cellular levels based on a self-developed data processing program. For effectively identify EGC, Raman spectroscopy was used combined with multiple machine learning methods, including partial least-squares discriminant analysis (PLS-DA), support vector machine (SVM), and convolutional neural network (CNN) with leave-one-out (LOO) cross validation. A total of 450 Raman spectra were investigated in this study. The upregulation of nu sym(O-P-O) backbone (p < 0.001) was identified as a favorable factor for the diagnosis of EGC, the area under the ROC curve (AUC) was up to 0.918. In addition, higher levels of lactic acid (p < 0.001), lipids (p < 0.001), phenylalanine (p = 0.002), and carotenoids (p < 0.001) were detected in EGC. Multivariate machine learning methods for diagnosis of EGC based on Raman spectroscopy, the sensitivity, specificity, accuracy, and AUC were 91.0%, 100%, 94.8%, and 95.8% for SVM, and 84.8%, 92.0%, 88.8%, and 95.5% for CNN, respectively. Raman spec-troscopy can be used as a powerful tool for detecting EGC while elucidating biomolecular dynamics in tumor-igenesis. (Chictr.org.cn, ChiCTR2200060720.)
Microsatellite Instability Detection in Cancer: A Multiplex qPCR Approach that Obviates the Need for Matching Normal Samples

Wei Chen,Yan Helen Yan,Blake Young,Alessandro Pinto,Qi Jiang,Nanjia Song,Adam Yaseen,Weijie Yao,David Yu Zhang,Jinny Xuemeng Zhang

DOI: https://doi.org/10.1093/clinchem/hvae045

IF: 12.114

2024-04-06

Clinical Chemistry

Abstract:Abstract Background Microsatellite instability (MSI) indicates DNA mismatch repair deficiency in certain types of cancer, such as colorectal cancer. The current gold standard technique, PCR–capillary electrophoresis (CE), requires matching normal samples and specialized instrumentation. We developed VarTrace, a rapid and low-cost quantitative PCR (qPCR) assay, to evaluate MSI using solely the tumor sample DNA, obviating the requirement for matching normal samples. Methods One hundred and one formalin-fixed paraffin-embedded (FFPE) tumor samples were tested using VarTrace and compared with the Promega OncoMate assay utilizing PCR-CE. Tumor percentage limit of detection was evaluated on contrived samples derived from clinical high MSI (MSI-H) samples. Analytical sensitivity, specificity, limit of detection, and input requirements were assessed using synthetic commercial reference standards. Results VarTrace successfully analyzed all 101 clinical FFPE samples, demonstrating 100% sensitivity and 98% specificity compared to OncoMate. It detected MSI-H with 97% accuracy down to 10% tumor. Analytical studies using synthetic samples showed a limit of detection of 5% variant allele frequency and a limit of input of 0.5 ng. Conclusions This study validates VarTrace as a swift, accurate, and economical assay for MSI detection in samples with low tumor percentages without the need for matching normal DNA. VarTrace's capacity for highly sensitive MSI analysis holds potential for enhancing the efficiency of clinical work flows and broadening the availability of this test.

medical laboratory technology
Evaluating the Microsatellite Instability of Colorectal Cancer Based on Multimodal Deep Learning Integrating Histopathological and Molecular Data

Wenjing Qiu,Jiasheng Yang,Bing Wang,Min Yang,Geng Tian,Peizhen Wang,Jialiang Yang

DOI: https://doi.org/10.3389/fonc.2022.925079

IF: 4.7

2022-07-05

Frontiers in Oncology

Abstract:Microsatellite instability (MSI), an important biomarker for immunotherapy and the diagnosis of Lynch syndrome, refers to the change of microsatellite (MS) sequence length caused by insertion or deletion during DNA replication. However, traditional wet-lab experiment-based MSI detection is time-consuming and relies on experimental conditions. In addition, a comprehensive study on the associations between MSI status and various molecules like mRNA and miRNA has not been performed. In this study, we first studied the association between MSI status and several molecules including mRNA, miRNA, lncRNA, DNA methylation, and copy number variation (CNV) using colorectal cancer data from The Cancer Genome Atlas (TCGA). Then, we developed a novel deep learning framework to predict MSI status based solely on hematoxylin and eosin (H&E) staining images, and combined the H&E image with the above-mentioned molecules by multimodal compact bilinear pooling. Our results showed that there were significant differences in mRNA, miRNA, and lncRNA between the high microsatellite instability (MSI-H) patient group and the low microsatellite instability or microsatellite stability (MSI-L/MSS) patient group. By using the H&E image alone, one can predict MSI status with an acceptable prediction area under the curve (AUC) of 0.809 in 5-fold cross-validation. The fusion models integrating H&E image with a single type of molecule have higher prediction accuracies than that using H&E image alone, with the highest AUC of 0.952 achieved when combining H&E image with DNA methylation data. However, prediction accuracy will decrease when combining H&E image with all types of molecular data. In conclusion, combining H&E image with deep learning can predict the MSI status of colorectal cancer, the accuracy of which can further be improved by integrating appropriate molecular data. This study may have clinical significance in practice.

oncology
Building fuzzy-qualitative models for simulation and control

R. Gorez,M. D. Neyer,J. Barreto

DOI: https://doi.org/10.1016/0928-4869(95)00046-1

1996-09-15

Simulation Practice and Theory

Abstract:
Intratumoral and peritumoral CT-based radiomics for predicting the microsatellite instability in gastric cancer

Xingchi Chen,Zijian Zhuang,Lin Pen,Jing Xue,Haitao Zhu,Lirong Zhang,Dongqing Wang

DOI: https://doi.org/10.1007/s00261-023-04165-9

IF: 2.4

2024-02-03

Abdominal Radiology

Abstract:To investigate the value of intratumoral and peritumoral radiomics based on contrast-enhanced computer tomography (CECT) to preoperatively predict microsatellite instability (MSI) status in gastric cancer (GC) patients.

radiology, nuclear medicine & medical imaging
Development and validation of magnetic resonance imaging- based radiomics models for preoperative prediction of microsatellite instability in rectal cancer

Wei Zhang,Zixing Huang,Jian Zhao,Du He,Mou Li,Hongkun Yin,Song Tian,Huiling Zhang,Bin Song

DOI: https://doi.org/10.21037/atm-20-7673

IF: 3.616

2021-01-01

Annals of Translational Medicine

Abstract:BACKGROUND: Microsatellite instability (MSI) is a predictive biomarker for response to chemotherapy and a prognostic biomarker for clinical outcomes of rectal cancer. The purpose of this study was to develop and validate radiomics models for preoperative prediction of the MSI status of rectal cancer based on magnetic resonance (MR) images.METHODS: This study retrospectively recruited 491 rectal cancer patients with pathologically confirmed MSI status. Patients were randomly divided into a training cohort (n=327) and a validation cohort (n=164). The most predictive radiomics features were selected using intraclass correlation coefficient (ICC) analysis, the two-sample <i>t</i> test, and the least absolute shrinkage and selection operator (LASSO) method. XGBoost models were constructed in the training cohort to discriminate the MSI status using clinical factors, radiomics features, or a combined model incorporating both the radiomics signature and independent clinical characteristics. The diagnostic performance of these three models was evaluated in the validation cohort based on their area under the curve (AUC), sensitivity, specificity, and accuracy.RESULTS: Among the 491 rectal cancer patients, the prevalence of MSI was 10.39% (51/491). Following ICC analysis, two-sample <i>t</i> test, and LASSO regression, six radiomics features were selected for subsequent analysis. The combined model, which incorporated both the clinical factors and radiomics features achieved an AUC of 0.895 [95% confidence interval (CI), 0.838-0.938] in the validation cohort, and showed better performance in predicting MSI status than the other two models using either clinical factors (P=0.015) or radiomics features (P=0.204) alone.CONCLUSIONS: Radiomics features based on preoperative T2-weighted MR imaging (MRI) are associated with the MSI status of rectal cancer. Combinational analysis of clinical factors and radiomics features may improve predictive performance and potentially contribute to noninvasive personalized therapy selection.

oncology,medicine, research & experimental
The value of single-source dual-energy CT imaging for discriminating microsatellite instability from microsatellite stability human colorectal cancer

Jingjun Wu,Yue Lv,Nan Wang,Ying Zhao,Pengxin Zhang,Yijun Liu,Anliang Chen,Jianying Li,Xin Li,Yan Guo,Tingfan Wu,Ailian Liu

DOI: https://doi.org/10.1007/s00330-019-06144-5

IF: 7.034

2019-03-22

European Radiology

Abstract:ObjectivesTo demonstrate the value of single-source dual-energy computed tomography (ssDECT) imaging for discriminating microsatellite instability (MSI) from microsatellite stability (MSS) colorectal cancer (CRC).MethodsThirty-eight and seventy-six patients with pathologically proven MSI and MSS CRC, respectively, were retrospectively selected and compared. These patients underwent contrast-enhanced abdominal ssDECT scans before any anti-cancer treatment. Effective atomic number (Eff-Z) in precontrast phase, slope k of spectral HU curve in precontrast (k-P), arterial (k-A), venous (k-V), and delayed phase (k-D), normalized iodine concentration in arterial (NIC-A), venous (NIC-V), and delayed phase (NIC-D), of tumors in two groups were measured by two reviewers. Consistency of measurements was tested by intra-class correlation coefficients (ICC). Mann-Whitney U test or Student’s t test was used to compare above values between MSI and MSS. Multivariate logistic regression was used to analyze multiple parameters. Receiver operating characteristic curves were calculated to assess diagnostic efficacies.ResultsInterobserver agreement was excellent (ICC > 0.80). MSI CRC had significantly lower values in all measurements (NIC-A, V, D; k-P, A, V, D; Eff-Z) than MSS CRC. For discriminating MSI from MSS CRC, the area under curve (AUC) using k-A was the highest (AUC, 0.803; sensitivity, 72.4%; specificity, 76.3%). The multivariate logistic regression (selection method, Enter) with combined ssDECT parameters (NIC-A, NIC-V, NIC-D, Eff-Z, k-P, k-A, k-V, k-D) significantly improved diagnostic capability with AUC of 0.886 (sensitivity, 81.6%; specificity, 81.6%).ConclusionsThe combination of multiple parameters in ssDECT imaging by multivariate logistic regression provides relatively high diagnostic accuracy for discriminating MSI from MSS CRC.Key Points• ssDECT generates multiple parameters for discriminating CRC with MSI from MSS.• ssDECT measurements for MSI CRC were significantly lower than MSS CRC.• Combination of ssDECT parameters further improves diagnostic capability for differentiation.

radiology, nuclear medicine & medical imaging
A Novel Method for Microsatellite Instability Detection by Liquid Biopsy Based on Next-generation Sequencing

Zheng Jiang,Hui Liu,Siwen Zhang,Jia Liu,Weitao Wang,Guoliang Zang,Bo Meng,Huixin Lin,Jichuan Quan,Shuangmei Zou,Dawei Yuan,Xishan Wang,Geng Tian,Jidong Lang

DOI: https://doi.org/10.2174/1574893615666200324133451

2020-01-01

Current Bioinformatics

Abstract:Background: Microsatellite instability (MSI) is a prognostic biomarker used to guide medication selection in multiple cancers, such as colorectal cancer. Traditional PCR with capillary electrophoresis and next-generation sequencing using paired tumor tissue and leukocyte samples are the main approaches for MSI detection due to their high sensitivity and specificity. Currently, patient tissue samples are obtained through puncture or surgery, which causes injury and risk of concurrent disease, further illustrating the need for MSI detection by liquid biopsy. Methods: We propose an analytic method using paired plasma/leukocyte samples and MSI detection using next-generation sequencing technology. Based on the theoretical progress of oncogenesis, we hypothesized that the microsatellite site length in plasma equals the combination of the distribution of tumor tissue and leukocytes. Thus, we defined a window-judgement method to identify whether biomarkers were stable. Results: Compared to traditional PCR as the standard, we evaluated three methods in 20 samples (MSI-H:3/MSS:17): peak shifting method using tissue vs. leukocytes, peak shifting method using plasma vs. leukocytes, and our method using plasma vs. leukocytes. Compared to traditional PCR, we observed a sensitivity of 100%, 0%, and 100%, and a specificity of 100.00%, 94.12%, and 88.24%, respectively. Conclusion: Our method has the advantage of possibly detecting MSI in a liquid biopsy and provides a novel direction for future studies to increase the specificity of the method.
Clinical performance of the TrueMark™ MSI assay for microsatellite instability detection in a Chinese colorectal cancer cohort

Erjiang Tang,Cui Tang,Xuejing Lin,Ying Chen,Yi Zhou,Chenyu Pan,Huihong Jiang

DOI: https://doi.org/10.1016/j.gene.2024.148745

IF: 3.913

2024-11-15

Gene

Abstract:Background: Microsatellite instability (MSI) and mismatch repair (MMR) detection is valuable in assessing prognosis and treatment options. However, the conventional detection methods such as immunohistochemistry (IHC) are limited by not fully consistent results as well as a long turnaround time. TrueMark™ MSI Assay is a novel solution for MSI analysis, but lack of research support in the Chinese colorectal cancer (CRC) patients. Materials and methods: 60 dMMR and 60 pMMR CRC samples identified by IHC were collected and their MSI status were detected using TrueMark™ MSI assay with an expanded panel of 13 markers. The overall performance and diagnostic concordance between TrueMark™ MSI test and MMR IHC analysis were assessed and analyzed. Results: According to the TrueMark™ test, 55 out of the 120 (45.8 %) CRCs were identified as MSI-high (MSI-H) with an instability at ≥ 4/13 markers. Compared with the MMR IHC analysis, an overall percent agreement of 94.2 % and a Kappa of 0.883 were achieved. For the seven inconsistent samples, tumor mutation burden analysis was performed and the results supported the diagnosis by TrueMark™ test. To confirm the robustness of the above findings, a validation was performed in an independent cohort comprising 51 consecutive CRCs. Furthermore, an optimized panel composed of NR-21, NR-24, NR-27, ABI-16, ABI-17 and ABI-20B was developed by multivariate logistic regression model, and showed 100 % agreement with the 13-marker panel for MSI detection in both the derivation and validation sets. Conclusion: TrueMark™ MSI provides a fast, reliable and highly automated solution to MSI detection in Chinese CRC patients, and the new 6-marker panel we established shows promise deserving further evaluation.
Effective atomic numbers for photon energy absorption and photon attenuation of tissues from human organs.

Shivaramu

DOI: https://doi.org/10.1016/S0958-3947(01)00078-4

IF: 1.531

2002-03-01

Medical Dosimetry

Abstract:
Synthesis of new tricyclic melatoninergic ligands.

A. Tsotinis,M. Panoussopoulou,S. Sivananthan,D. Sugden

DOI: https://doi.org/10.1016/S0014-827X(01)01125-9

2001-08-01

Il Farmaco

Abstract:
Accuracy of machine learning in diagnosing microsatellite instability in gastric cancer: A systematic review and meta-analysis

Yuou Ying,Ruyi Ju,Jieyi Wang,Wenkai Li,Yuan Ji,Zhenyu Shi,Jinhan Chen,Mingxian Chen

DOI: https://doi.org/10.1016/j.ijmedinf.2024.105685

IF: 4.73

2024-11-04

International Journal of Medical Informatics

Abstract:Background Significant challenges persist in the early identification of microsatellite instability (MSI) within current clinical practice. In recent years, with the growing utilization of machine learning (ML) in the diagnosis and management of gastric cancer (GC), numerous researchers have explored the effectiveness of ML methodologies in detecting MSI. Nevertheless, the predictive value of these approaches still lacks comprehensive evidence. Accordingly, this study was carried out to consolidate the accuracy of ML in the prompt detection of MSI in GC. Methods PubMed, the Cochrane Library, the Web of Science, and Embase were retrieved up to March 20, 2024. The risk of bias in the encompassed studies was evaluated utilizing a risk assessment tool for predictive models. Models were then subjected to subgroup analysis based on the modeling variables. Results A total of 12 studies, encompassing 11,912 patients with GC, satisfied the predefined inclusion criteria. ML models established in these studies were primarily based on pathological images, clinical features, and radiomics. The results suggested that in the validation sets, the pathological image-based models had a synthesized c-index of 0.86 [95 % CI (0.83–0.89)], with sensitivity and specificity being 0.86 [95 % CI (0.76–0.92)] and 0.83 [95 % CI (0.78–0.87)], respectively; radiomics feature-based models achieved respective values of 0.87 [95 % CI (0.81–0.92)], 0.77 [95 % CI (0.70–0.83)] and 0.81 [95 % CI (0.74–0.87)]; radiomics feature-based models + clinical feature-based models achieved respective values of 0.87 [95 % CI (0.81–0.93)], 0.78 [95 % CI (0.70–0.84)] and 0.79 [95 % CI (0.69–0.86)]. Conclusions ML has demonstrated optimal performance in detecting MSI in GC and could serve as a prospective early adjunctive detection tool for MSI in GC. Future research should contemplate minimally invasive or non-invasive, readily collectible, and efficient predictors to augment the predictive accuracy of ML.

health care sciences & services,computer science, information systems,medical informatics
scMSI: Accurately inferring the sub-clonal Micro-Satellite status by an integrated deconvolution model on length spectrum

Yuqian Liu,Yan Chen,Huanwen Wu,Xuanping Zhang,Yuqi Wang,Xin Yi,Zhiyong Liang,Jiayin Wang

DOI: https://doi.org/10.1371/journal.pcbi.1012608

2024-12-03

PLoS Computational Biology

Abstract:Microsatellite instability (MSI) is an important genomic biomarker for cancer diagnosis and treatment, and sequencing-based approaches are often applied to identify MSI because of its fastness and efficiency. These approaches, however, may fail to identify MSI on one or more sub-clones for certain cancers with a high degree of heterogeneity, leading to erroneous diagnoses and unsuitable treatments. Besides, the computational cost of identifying sub-clonal MSI can be exponentially increased when multiple sub-clones with different length distributions share MSI status. Herein, this paper proposes "scMSI", an accurate and efficient estimation of sub-clonal MSI to identify the microsatellite status. scMSI is an integrative Bayesian method to deconvolute the mixed-length distribution of sub-clones by a novel alternating iterative optimization procedure based on a subtle generative model. During the process of deconvolution, the optimized division of each sub-clone is attained by a heuristic algorithm, aligning with clone proportions that adhere optimally to the sample's clonal structure. To evaluate the performance, 16 patients diagnosed with endometrial cancer, exhibiting positive responses to the treatment despite having negative MSI status based on sequencing-based approaches, were considered. Excitingly, scMSI reported MSI on sub-clones successfully, and the findings matched the conclusions on immunohistochemistry. In addition, testing results on a series of experiments with simulation datasets concerning a variety of impact factors demonstrated the effectiveness and superiority of scMSI in detecting MSI on sub-clones over existing approaches. scMSI provides a new way of detecting MSI for cancers with a high degree of heterogeneity. Microsatellites are short, repetitive sequences of DNA, and their instability (MSI) is an important marker for cancer diagnosis and treatment. However, tumors often consist of diverse groups of cells, or sub-clones, and existing sequencing methods often fail to detect MSI that occurs only in some sub-clones. This can lead to incorrect diagnoses and prevent patients from receiving the most effective therapies. To solve this problem, we developed a new computational method named as scMSI to accurately identify MSI of sub-clones within a tumor. scMSI utilizes advanced statistical techniques to deconvolute the complex mixture of genetic mutations. As a result, we can use scMSI to detect sub-clonal MSI that other methods might miss. In the testing, we examined scMSI on samples from 16 patients with endometrial cancer, who had been incorrectly labeled as MSI-negative by existing methods. Our method successfully identified MSI in sub-clones, showing that scMSI outperforms existing tools. Additionally, simulation experiments under various conditions further confirmed the effectiveness of scMSI in detecting sub-clonal MSI. By improving the detection of MSI in cancers with a high degree of heterogeneity, scMSI can enhance cancer diagnosis and treatments more effectively.

biochemical research methods,mathematical & computational biology
Non-invasive CT radiomic biomarkers predict microsatellite stability status in colorectal cancer: a multicenter validation study

Zuhir Bodalal,Eun Kyoung Hong,Stefano Trebeschi,Ieva Kurilova,Federica Landolfi,Nino Bogveradze,Francesca Castagnoli,Giovanni Randon,Petur Snaebjornsson,Filippo Pietrantonio,Jeong Min Lee,Geerard Beets,Regina Beets-Tan

DOI: https://doi.org/10.1186/s41747-024-00484-8

2024-08-26

Abstract:Background: Microsatellite instability (MSI) status is a strong predictor of response to immunotherapy of colorectal cancer. Radiogenomic approaches promise the ability to gain insight into the underlying tumor biology using non-invasive routine clinical images. This study investigates the association between tumor morphology and the status of MSI versus microsatellite stability (MSS), validating a novel radiomic signature on an external multicenter cohort. Methods: Preoperative computed tomography scans with matched MSI status were retrospectively collected for 243 colorectal cancer patients from three hospitals: Seoul National University Hospital (SNUH); Netherlands Cancer Institute (NKI); and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Italy (INT). Radiologists delineated primary tumors in each scan, from which radiomic features were extracted. Machine learning models trained on SNUH data to identify MSI tumors underwent external validation using NKI and INT images. Performances were compared in terms of area under the receiving operating curve (AUROC). Results: We identified a radiomic signature comprising seven radiomic features that were predictive of tumors with MSS or MSI (AUROC 0.69, 95% confidence interval [CI] 0.54-0.84, p = 0.018). Integrating radiomic and clinical data into an algorithm improved predictive performance to an AUROC of 0.78 (95% CI 0.60-0.91, p = 0.002) and enhanced the reliability of the predictions. Conclusion: Differences in the radiomic morphological phenotype between tumors MSS or MSI could be detected using radiogenomic approaches. Future research involving large-scale multicenter prospective studies that combine various diagnostic data is necessary to refine and validate more robust, potentially tumor-agnostic MSI radiogenomic models. Relevance statement: Noninvasive radiomic signatures derived from computed tomography scans can predict MSI in colorectal cancer, potentially augmenting traditional biopsy-based methods and enhancing personalized treatment strategies. Key points: Noninvasive CT-based radiomics predicted MSI in colorectal cancer, enhancing stratification. A seven-feature radiomic signature differentiated tumors with MSI from those with MSS in multicenter cohorts. Integrating radiomic and clinical data improved the algorithm's predictive performance.

[Regulation mechanism of fibrinolysis system on vascular wall].

A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study

A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing.

Raman fiber-optic probe for rapid diagnosis of gastric and esophageal tumors with machine learning analysis or similarity assessments: a comparative study

Distinct roles of the mTOR components Rictor and Raptor in MO7e megakaryocytic cells

Raman Spectroscopy: A Novel Technology for Gastric Cancer Diagnosis

[Studies of Microsatellite Instability in Chinese Gastric Cancer Tissues].

A Novel Detection Technology for Early Gastric Cancer Based on Raman Spectroscopy.

Microsatellite Instability Detection in Cancer: A Multiplex qPCR Approach that Obviates the Need for Matching Normal Samples

Evaluating the Microsatellite Instability of Colorectal Cancer Based on Multimodal Deep Learning Integrating Histopathological and Molecular Data

Building fuzzy-qualitative models for simulation and control

Intratumoral and peritumoral CT-based radiomics for predicting the microsatellite instability in gastric cancer

Development and validation of magnetic resonance imaging- based radiomics models for preoperative prediction of microsatellite instability in rectal cancer

The value of single-source dual-energy CT imaging for discriminating microsatellite instability from microsatellite stability human colorectal cancer

A Novel Method for Microsatellite Instability Detection by Liquid Biopsy Based on Next-generation Sequencing

Clinical performance of the TrueMark™ MSI assay for microsatellite instability detection in a Chinese colorectal cancer cohort

Effective atomic numbers for photon energy absorption and photon attenuation of tissues from human organs.

Synthesis of new tricyclic melatoninergic ligands.

Accuracy of machine learning in diagnosing microsatellite instability in gastric cancer: A systematic review and meta-analysis

scMSI: Accurately inferring the sub-clonal Micro-Satellite status by an integrated deconvolution model on length spectrum

Non-invasive CT radiomic biomarkers predict microsatellite stability status in colorectal cancer: a multicenter validation study